"For an immunotherapy treatment to be efficient, we use a fluorescent microscope in the operating theatre, which increases the percentage of tumorous tissue removed".
DR. BARTOLOMÉ BEJARANO
SPECIALIST. BRAIN TUMOUR AREA
Glioblastomas are tumors that arise from the supporting cells of brain tissue.
They can be primary tumors, which originate from the very cells that make up the various brain structures, or metastatic, which have spread to the brain from another extracerebral location. The latter are 10 times more frequent than primary brain tumors.
The Clinica Universidad de Navarra has a Brain Tumor Area which has a highly specialized team of experts and the most advanced technology for the diagnosis and treatment of glioblastoma.
We are the only Spanish center that incorporates high field intraoperative magnetic resonance imaging (3T). This allows the maximum precision and control in cranial surgery.
The Clinic has the series of patients with the highest average volume of glioblastoma removal. With the fluorescence microscope, complete removal is achieved in 83% of cases.
In addition, we are at the forefront of both treatment and research: we are the only Spanish center that carries out a study for the treatment of glioblastomas with immunotherapy through personalized vaccines combined with the standard first-line treatment.
A PERSONALIZED MEDICINE
peace of mind
Request a second opinion from our professionals with great experience in the diagnosis and treatment of oncological diseases
In 72 hours, without leaving home.
What are the symptoms of malignant glioblastoma?
Headache is the most frequent non-specific symptom. In many occasions, it is difficult that its presence makes us suspect the presence of a brain tumor.
The symptoms derived from the increase of the intracranial pressure, like somnolence, can be more indicative of the presence of a glioma.
There are other more specific signs and symptoms that appear depending on the location of the disease, such as focal signs (loss of strength, difficulty speaking or visual field deficit), seizures and bleeding.
The use of the fluorescent microscope manages to duplicate the complete removals of malignant brain tumors (available in spanish).
Do you have any of these symptoms?
You may have a glioblastoma multiforme
What causes glioblastoma?
There is no known cause responsible for the appearance of gliomas.
Less than 5% of gliomas have a family history.
In addition, there are various degenerative brain diseases that predispose to gliomas.
Nor has it been demonstrated that frequent use of cell phones is the cause of a higher incidence of these brain tumors.
What is your prognosis?
Low grade gliomas I and II
The factors of good prognosis are:
- Being under 40 years old.
- Tumor diameter less than 6 cm.
- Tumor that does not exceed the midline.
- Histological type oligoastrocytoma.
- Absence of neurological deficits.
Survival in these patients with high-grade tumors ranges from 9 to 2 years depending on the prognosis group.
Gliomas III and IV
The factors of good prognosis are:
- Age (less than 40-50 years).
- To have a good general condition with autonomy.
- Normal mental state.
- To achieve a complete surgical resection.
Survival in these patients with high-grade tumors ranges from 2 years to 6 months depending on the prognosis group.
How is glioblastoma diagnosed?
The Clinic has the most advanced imaging tests.
The magnetic resonance allows to see the lesions of the cerebral tissue, their location and size.
By adding the most sophisticated MRI sequences and PET with methionine, the type of tumor can be specified.
It is possible to transfer this information to navigation devices in the operating room that correlate those images with the actual space in which one is working.
- The obtaining of tissue and its analysis by a neuropathologist is necessary to establish an accurate diagnosis of the type and grade of the tumor.
- It can be done by open surgery or by image-guided puncture (stereotactic technique).
- The stereotactic technique means less discomfort for the patient. With a meticulous technique, in the operating room and in the laboratory, it is possible to obtain a sample of sufficient quality and quantity to diagnose and perform the necessary molecular markers.
It detects the existence of the glioma and its degree of malignancy in cases where, due to its location, it is impossible to perform a biopsy.
How is glioblastoma multiforme treated?
The Clinic has the series of patients with the highest average volume of glioblastoma removal.
It uses a novel technique, the fluorescence microscope, which achieves the complete removal of the glioblastoma in 83% of the cases. These data have been published in international scientific journals.
In general, if the entire tumor part is removed, grade 1 and some grade 2 tumors can be cured by surgery alone.
In low-grade tumors that cannot be completely operated on and in grade 3 and 4 tumors, surgery should be followed by radiation and chemotherapy treatments.
Chemotherapy has been shown to be effective in prolonging survival in high-grade gliomas.
The current standard is to use temozolomide at the same time as radiotherapy and at least 6 cycles later.
In addition to this standard treatment, there are other options for which new data are emerging every year. The use of these second lines, whose use is more complex, depends on each case and the experience of the oncologist.
In spite of all the treatments, in many cases of high grade gliomas or glioblastoma the progression of the disease is not stopped, that is why it is important to continue studying with basic research and clinical trials.
Precision in the planning and execution of radiation therapy is essential to ensure that the maximum dose is delivered to the tumor, while preserving normal tissues.
This accuracy depends on the specialist's experience and care in planning, the imaging tests available for planning, and the equipment available.
Innovative techniques are used such as three-dimensional conformal radiotherapy, beam intensity modulated radiotherapy, and stereotactic techniques that require state-of-the-art linear accelerators and significant computer support.
In high-grade gliomas, the treatment that has demonstrated the greatest survival is the combination of surgery, radiotherapy at a higher dose than in low-grade gliomas, and chemotherapy. The component of post-operative treatment that has shown the greatest benefit is radiotherapy.
La Clínica is the only Spanish center that carries out a study for the treatment of glioblastomas with immunotherapy.
The new therapy, which is administered to participating patients in the form of vaccines, is combined with standard first-line treatment. It consists of the surgical removal of the tumor, followed by the administration of radiotherapy and chemotherapy with temozolomide.
The immune system is critical in the development and control of tumors. Immunotherapy aims to repair or increase the response of the patient's immune system.
The limited amount of disease and the combination of chemotherapy and immunotherapy make this a good added option to the treatment of patients with glioblastoma.
What clinical trials do we have on glioblastoma?
Proton therapy against cancer
Proton therapy is the most precise external radiotherapy modality, providing better distribution of radiation dose and therefore less irradiation of healthy tissues.
The Proton Therapy Unit of the Clínica Universidad de Navarra in its Madrid headquarters is the most advanced in Europe and the first in a Cancer Center, with all its healthcare, academic and research support.
Where do we treat it?
IN NAVARRE AND MADRID
OUR MEDICAL TEAM
Brain Tumor Specialists
In the Brain Tumor Area we offer maximum safety and efficiency in brain tumor surgery, being the first hospital with a high field magnetic resonance within the operating room.
We have a highly specialized team in the surgery of brain tumors, with more than 15 years of experience.
The individualized treatment of each case by an interdisciplinary team allows us to offer the best alternative to each patient.
Why at the Clinica?
- Integral evaluation of the patient.
- Cutting edge technology.
- Expert professionals who are a national reference.
Our team of professionals
Safer than ever to continue taking care of you
We update safety protocols weekly with the latest scientific evidence and the knowledge of the best international centers with which we collaborate.